Error processing SSI file
Error processing SSI file
Weekly Report: Influenza Summary Update
Week ending January 18, 2003-Week 3
Error processing SSI fileThe following information may be quoted:
Synopsis:
During week 3 (January 12-18, 2003)*, 150 (10.6%) of the
specimens tested by World Health Organization (WHO) and National
Respiratory and Enteric Virus Surveillance System (NREVSS)
laboratories were positive for influenza. The proportion
of patient visits to sentinel providers for influenza-like
illness (ILI) overall was 1.5%, which is less than the national
baseline of 1.9%. The proportion of deaths attributed to
pneumonia and influenza was 7.5%. Three state and territorial
health departments reported widespread influenza activity,
11 reported regional activity, 29 reported sporadic activity,
and 5 reported no influenza activity**.
Laboratory Surveillance*:
During week 3, WHO and NREVSS
laboratories reported 1,414 specimens tested for influenza
viruses, of which 150 (10.6%) were positive. Ten influenza
A (H1)† viruses, three influenza A (H3N2) viruses, 23 unsubtyped
influenza A viruses, and 114 influenza B viruses were identified.
During the past 3 weeks (weeks 1-3), 23.0% of the specimens
tested for influenza in the New England region*** were
positive. Between 11.8% and 18.2% of specimens tested for
influenza during the past 3 weeks in the West North Central
and West South Central regions were positive and between
1.7% and 5.5% of the specimens tested for influenza during
the past 3 weeks were positive in the Pacific, Mountain,
East South Central, East North Central, South Atlantic,
and Mid-Atlantic regions.
Since September 29, WHO and NREVSS laboratories have tested
a total of 30,942 specimens for influenza viruses and 950
(3.1%) were positive. Of the 950 viruses identified, 241
(25%) were influenza A viruses and 709 (75%) were influenza
B viruses. Ninety-three (39%) of the 241 influenza A viruses have been subtyped;
78 (84%) were influenza A (H1)† viruses and 15 (16%) were influenza A (H3N2)
viruses. Five hundred and thirty-five (75%) of the 709 influenza B viruses
were identified in Texas and Missouri. Forty-two states have reported laboratory-confirmed
influenza. Influenza A and influenza B viruses have been identified in 21
states (AZ, CA, CO, DE, FL, IA, IN, LA, MA, MO, MT, NC, NE, NM, NY, OK, SC,
TX, VA, WA, WI). Fourteen states (AL, CT, HI, IL, MI, MN, NJ, OH, OR, SD, TN,
UT, VT, and WY) have reported only influenza A viruses and 7 states (AR, KS,
KY, NH, NV, PA, and WV) have reported only influenza B viruses. Influenza A
viruses were reported more frequently than influenza B viruses (range 56% -
88%) in the East North Central, Mid-Atlantic, New England, Pacific, and South
Atlantic regions, and influenza B viruses were reported more frequently than
influenza A viruses (range 54% - 83%) in the East South Central, Mountain,
West North Central, and West South Central regions.

Antigenic Characterization of Viral Isolates:
CDC has antigenically characterized 62 influenza viruses submitted by U.S. laboratories since September 29: thirty-two influenza B viruses, 18 influenza A (H3N2) viruses, and 12 influenza A (H1)† viruses. Eleven of the influenza A (H1) viruses had the N1 neuraminidase and one had the N2 neuraminidase. The influenza B viruses, the A (H3N2) viruses, and the hemagglutinin proteins of the A (H1N1) and A (H1N2) viruses were similar antigenically to those of the corresponding vaccine strains B/Hong Kong/330/01, A/Panama/2007/99 (H3N2), and A/New Caledonia/20/99 (H1N1), respectively.
Click here for more information about influenza A (H1N2) viruses
Pneumonia and Influenza (P&I) Mortality Surveillance:
During
week 3, the percentage of all deaths due to pneumonia and
influenza as reported by the vital statistics offices of
122 U.S. cities was 7.5%. This percentage is below the
epidemic threshold of 8.1% for week 3.

Influenza-like Illness Surveillance *:
During week 3, 1.5% of patient visits to U.S. sentinel providers were due to ILI. This percentage is less than the national baseline of 1.9%. On a regional level***, the percentage of visits for ILI ranged from 1.1% to 4.0%. Due to wide variability in regional level data, it is not appropriate to apply the national baseline to regional level data.

Influenza Activity as Assessed by State and Territorial Epidemiologists**:
Influenza activity was reported as widespread in Missouri, North Carolina, and Texas, and regional in 11 states. Twenty-nine states and New York City reported sporadic activity, 5 states reported no influenza activity, and 2 states did not report.
* Reporting is incomplete for this week. Numbers may change
as more reports are received.
** Influenza activity is defined as influenza-like illness and/or culture-confirmed
influenza.
†Includes both the A (H1N1) and A (H1N2) influenza virus subtypes. The influenza
A (H1N2) strain appears to have resulted from the reassortment of the genes of
currently circulating influenza A (H1N1) and A (H3N2) subtypes. Because the hemagglutinin
proteins of the A (H1N2) viruses are similar to those of the currently circulating
A (H1N1) viruses and the neuraminidase proteins are similar to those of the currently
circulating A (H3N2) viruses, the 2002-03 influenza vaccine should provide protection
against A (H1N2) viruses.
*** Surveillance Regions: New England (Connecticut, Maine,
Massachusetts, New Hampshire, Vermont, Rhode Island); Mid-Atlantic (New
Jersey, New York City, Pennsylvania, Upstate New York); East North
Central (Illinois, Indiana, Michigan, Ohio, Wisconsin); West
North Central (Iowa, Kansas, Minnesota, Missouri, Nebraska, North
Dakota, South Dakota); South Atlantic (Delaware, Florida,
Georgia, Maryland, North Carolina, South Carolina, Virginia, Washington, D.C.,
West Virginia); East South Central (Alabama, Kentucky, Mississippi,
Tennessee); West South Central (Arkansas, Louisiana, Oklahoma,
Texas); Mountain (Arizona, Colorado, Idaho, Montana, Nevada,
New Mexico, Utah, Wyoming); Pacific (Alaska, California, Hawaii,
Oregon, Washington)
Report prepared January 23, 2003
Error processing SSI file